drugs

Drugmakers accused of stalling biosimilars: FDA’s Gottlieb calls tactics ‘a toxin’

Food and Drug Administration Commissioner Scott Gottlieb on Wednesday [July 18] accused drug makers who manufacture pricey biologic medicines of ...
glp menu logo outlined

Newsletter Subscription

Optional. Mail on special occasions.